Qiagen Nv earnings were $402.2M for the trailing 12 months ending Mar 31, 2026, with 334.9% growth year over year. The latest QGEN earnings report on Mar 31, 2026 announced Q1 2026 earnings of $68.0M, down 36.9% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, QGEN reported annual earnings of $424.9M, with 408.3% growth.
QGEN past earnings growth
How has QGEN's earnings growth performed historically?
On QGEN's earnings call on Invalid Date, Qiagen Nv (NYSE: QGEN) reported Q1 2026 earnings per share (EPS) of $0.33, up 21.43% year over year. Total QGEN earnings for the quarter were $68.04 million. In the same quarter last year, Qiagen Nv's earnings per share (EPS) was $0.42.
As of the last Qiagen Nv earnings report, Qiagen Nv is currently profitable. Qiagen Nv's net profit (also called net income) for the twelve months ending Mar 31, 2026 was $402.17 million, a 329.31% increase year over year.
What was QGEN's earnings growth in the past year?
As of Qiagen Nv's earnings date in Invalid Date, Qiagen Nv's earnings has grown 334.88% year over year. This is 324.56 percentage points higher than the US Diagnostics & Research industry earnings growth rate of 10.32%. QGEN earnings in the past year totalled $402.17 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.